+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Naltrindole, a selective delta-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action



Naltrindole, a selective delta-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action



European Journal of Pharmacology 333(1): 47-54



The potentiation of the toxic and lethal effects of cocaine by the selective delta-opioid receptor antagonist naltrindole was explored in unrestrained, unanesthetized rats that received a continuous intravenous infusion of cocaine until death. The lethal dose of cocaine was lowered dose dependently in animals administered naltrindole intracisternally (3.0-30 microg), but not intravenously (30-300 microg). There was also a decrease in the lethal dose of cocaine following an injection of the nonselective opioid antagonist naltrexone, but not naloxone. However, the seizure-producing dose of cocaine was decreased dose dependently in rats that received naltrindole, regardless of the route of administration, naloxone, or naltrexone. In contrast, the effect of cocaine on heart rate was altered only by centrally administered naltrindole or intravenous naltrexone, with a dose of 30 microg naltrindole and 10 mg/kg naltrexone abolishing the bradycardic effect of cocaine. Despite this, neither naltrindole nor naltrexone changed the hypertensive effect of cocaine. Higher doses of naltrindole (100 microg i.c.) produced significant increases in heart rate and mean arterial pressure and were not tested in combination with cocaine. Because the lethal dose of cocaine was reduced only when naltrindole was administered intracisternally, the potentiation of the lethal effects of cocaine by naltrindole is through a central mechanism of action that may involve changes in cardiovascular function.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009075851

Download citation: RISBibTeXText

PMID: 9311660


Related references

Naltrindole , a selective delta-opioid receptor antagonist, potentiates cocaine-induced lethality in the rat. FASEB Journal 9(3): A401, 1995

The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. European Journal of Pharmacology 280(1): 55-61, 1995

Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. Neuroreport 6(10): 1409-1412, 1995

Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. British Journal of Pharmacology 107(2): 573-576, 1992

Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats. European Journal of Pharmacology 249(2): 161-165, 1993

Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement. Behavioural Brain Research 182(1): 140-144, 2007

Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole. European Journal of Pharmacology 219(2): 345-346, 1992

Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. European Journal of Pharmacology 243(2): 123-127, 1993

The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice. Psychopharmacology 113(2): 167-171, 1993

Naltrindole potentiates cocaine-induced toxicity in rats by a central mechanism of action. Society for Neuroscience Abstracts 21(1-3): 718, 1995

A naltrindole isothiocyanate nti ncs a selective nonequilibrium delta opioid receptor antagonist. Society for Neuroscience Abstracts 15(1): 544, 1989

Exploring delta-receptor function using the selective opioid antagonist naltrindole. Neuropharmacology 28(12): 1427-1430, 1989

Naltrindole-5'-isothiocyanate: a nonequilibrium, highly selective .delta.-opioid receptor antagonist. Journal of Medicinal Chemistry 33(6): 1547-1548, 1990

Selective acceleration of colonic propulsion by the opioid delta receptor antagonist, naltrindole. Gastroenterology 110(4 Suppl. ): A665, 1996

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. European Journal of Pharmacology 146(1): 185-186, 1988